Provided by Tiger Trade Technology Pte. Ltd.

CVRx, Inc.

1.75
-0.8800-33.46%
Post-market: 1.74-0.0100-0.57%19:52 EDT
Volume:4.27M
Turnover:8.48M
Market Cap:46.62M
PE:-0.89
High:2.65
Open:2.63
Low:1.65
Close:2.63
52wk High:11.30
52wk Low:1.65
Shares:26.64M
Float Shares:15.55M
Volume Ratio:8.93
T/O Rate:27.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9748
EPS(LYR):-2.0436
ROE:-133.44%
ROA:-28.70%
PB:2.34
PE(LYR):-0.86

Loading ...

CVRx Q2 Basic EPS USD -0.53

THOMSON REUTERS
·
Aug 07

CVRx Q2 Gross Profit USD 13.724 Million

THOMSON REUTERS
·
Aug 07

CVRx Reports Second Quarter 2026 Financial and Operating Results

GlobeNewswire
·
Aug 07

CVRx, Inc. Expected to Post a Loss of 52 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Lake Street Keeps Their Buy Rating on CVRx (CVRX)

TIPRANKS
·
Aug 03

CVRx’s REBALANCE Registry Update: What the Termination Means for Barostim Investors

TIPRANKS
·
Jul 31

CVRx to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Jul 28

Cvrx Updates Financial Calendar with Second-quarter 2026 Results Release, Conference Call

Reuters
·
Jul 24

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

GlobeNewswire
·
Jul 24

Analysts Are Bullish on These Healthcare Stocks: CVRx (CVRX), Opus Genetics (IRD)

TIPRANKS
·
Jul 07

CVRx CFO Announces Resignation and Leadership Transition Plan

TIPRANKS
·
Jun 09

CVRx Says CFO Jared Oasheim to Step Down

MT Newswires Live
·
Jun 09

CVRx CFO Jared Oasheim to step down

TIPRANKS
·
Jun 09

CVRx Chief Financial Officer Jared Oasheim Leaving

Dow Jones
·
Jun 09

CVRx CFO Jared Oasheim steps down, successor search begins

Reuters
·
Jun 09

CVRx - Oasheim to Remain With CVRx as Advisor Through February 2027

THOMSON REUTERS
·
Jun 09

Press Release: CVRx Announces Chief Financial Officer Transition

Dow Jones
·
Jun 09

CVRx Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jun 04

CVRx shareholders elect Class II directors at annual meeting

Reuters
·
Jun 04

CVRx to Present at Goldman Sachs Global Healthcare Conference

Reuters
·
May 28